Skip to main content
Genscript Biotech Corporation logo

Genscript Biotech Corporation — Investor Relations & Filings

Ticker · 1548 ISIN · KYG3825B1059 LEI · 529900YIYUOJOXSAE372 HKEX Manufacturing
Open in API
Filings indexed 820 across all filing types
Latest filing 2025-03-11 Earnings Release
Country KY Cayman Islands
Listing HKEX 1548

About Genscript Biotech Corporation

http://www.genscript.com/investor-relat…

Genscript Biotech Corporation is a world-leading technology and service provider specializing in life science research and manufacturing. The company offers a comprehensive portfolio of services and products essential for fundamental life science research, translational biomedical research, and early drug discovery and development. Core offerings include custom synthesis of genes, peptides, proteins, and antibodies, alongside molecular cloning and oligonucleotide production. GenScript also provides Contract Development and Manufacturing Organization (CDMO) solutions for innovative therapies through its specialized subsidiaries. The corporation leverages biotechnology and AI-driven approaches to advance life science solutions.

Recent filings

Filing Released Lang Actions
ANNUAL RESULTS ANNOUNCEMENT FOR THE YEAR ENDED DECEMBER 31, 2024
Earnings Release Classification · 1% confidence The document is titled “Annual Results Announcement for the Year Ended December 31, 2024” and is published as a stock exchange announcement by the company. It begins with key annual results highlights (revenue, profit/loss comparisons) followed by condensed financial statements (profit or loss, financial position, cash flows) and brief notes. This format corresponds to an initial earnings results announcement (annual earnings release) rather than a full integrated Annual Report (10-K) or other regulatory filing. Therefore, it should be classified as an Earnings Release. FY 2024
2025-03-11 English
INSIDE INFORMATION: FINANCIAL RESULTS FOR FOURTH QUARTER AND THE YEAR ENDED DECEMBER 31, 2024 OF A LISTED ASSOCIATE - LEGEND BIOTECH CORPORATION
Earnings Release Classification · 1% confidence The document is a Hong Kong Exchange announcement under Rule 13.09, titled “Financial Results for the Fourth Quarter and the Year Ended December 31, 2024,” with bullet-point highlights of CARVYKTI® sales, revenues, net income/loss, and key operational developments. It is a press release-style initial announcement of quarterly and annual period results rather than a full Annual Report (10-K) or a formal Interim Report (IR). It is not a conference call transcript, management discussion, or regulatory/filing notice of report publication. This matches the definition of an Earnings Release (ER). Q4 2024
2025-03-11 English
LIST OF DIRECTORS AND THEIR ROLE AND FUNCTION
Governance Information Classification · 1% confidence The document is a short regulatory announcement listing the board composition, individual director roles, and committee memberships. It is not an AGM presentation, earnings, or capital notice, and it does not announce changes in directorship but instead details the governance structure and board committee setup. This aligns with the Governance Information category, which covers reports on board structure and governance practices.
2025-03-11 English
REDESIGNATION OF DIRECTOR AND CHANGE OF COMPOSITION OF COMMITTEE
Board/Management Information Classification · 1% confidence The document is a Hong Kong Stock Exchange announcement concerning the redesignation of a director and changes to the composition of board committees (Audit, Remuneration, Nomination). It clearly relates to Board/Management Information (changes in the company’s board of directors and committee memberships).
2025-03-11 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 28 February 2025
Share Issue/Capital Change Classification · 1% confidence The document is a monthly return (Form FF301) submitted to Hong Kong Exchanges and Clearing Limited detailing movements in authorised share capital, issued shares, share options, and other share-related items for the month ended 28 February 2025. It is not an annual or interim financial report, nor an AGM or earnings release, but a scheduled regulatory filing on capital structure changes under the Exchange Listing Rules. This falls under Announcement regarding share issues or other capital changes (SHA).
2025-03-04 English
DATE OF BOARD MEETING
Report Publication Announcement Classification · 1% confidence The document is a brief announcement from a Hong Kong-listed company stating the date of a Board meeting to consider and approve the year-end results and dividend. It does not contain the actual financial statements or results, but merely announces the upcoming publication of the year-end report. This fits the “Report Publication Announcement” category (RPA), which covers announcements about the timing or release of reports.
2025-02-27 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.